Evidence map›Paper›PMID 41025162›Full record

ArticleAmerican journal of men's health

Male Infertility Management: A Critical Appraisal of Clinical Practice Guidelines With the AGREE II Instrument.

Jie Li, Kecheng Li, Mingqiang Zhang, Jixuan Chen, Maoke Chen, Wenxuan Dong, Wenhao Yu, Lixing Lei, Yao Huang, Haodong Yang and 3 more

Abstract read
In one paragraph

Article in American journal of men's health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jie LiDepartment of Andrology, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, China.ORCID 0009-0003-4992-4802
Kecheng LiDepartment of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Mingqiang ZhangDepartment of Andrology, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, China.ORCID 0009-0007-7118-3034
Jixuan ChenDepartment of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Maoke ChenDepartment of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Wenxuan DongDepartment of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Wenhao YuFirst Clinical Medical School, Beijing University of Chinese Medicine, Beijing, China.
Lixing LeiDepartment of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.ORCID 0009-0008-1763-6052
Yao HuangDepartment of Dermatology, Sanming Hospital of Integrated Traditional Chinese and Western Medicine, Sanming, China.
Haodong YangDepartment of Andrology, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, China.
Peixuan RenDepartment of Andrology, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, China.
Qiang ZouDepartment of Andrology, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, China.
Longsheng DengDepartment of Andrology, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, China.ORCID 0000-0002-0744-8575

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To systematically evaluate the quality of both domestic and international clinical practice guidelines for male infertility using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) tool, identify methodological shortcomings, and propose evidence-based recommendations for improvement, this study was conducted. A systematic search of Chinese and English databases, along with official websites of international organizations, was undertaken to identify relevant guidelines. Four independent reviewers assessed the included guidelines employing the AGREE II tool, focusing on the rigor of development processes and the concordance and divergence among core recommendations. Ten guidelines were included, with only one rated "recommendable" using AGREE II criteria; others were "conditionally recommendable" or "not recommendable." Key shortcomings included deficient rigor of development (Domain III: 34.4%), applicability (Domain V: 48.3%), and editorial independence (Domain VI: 23.5%). Eighteen core recommendations were identified. Domestic guidelines lacked transparent conflict of interest disclosures and multidisciplinary collaboration, whereas international guidelines demonstrated superior methodological rigor through interprofessional integration. Most guidelines failed to validate clinical impacts of recommendations, hindering practical implementation. This study represents the first systematic evaluation of male infertility guidelines at national and international levels, with comparative analysis of their recommendations. Findings reveal widespread deficiencies in methodological rigor, applicability, and editorial independence. Future guideline development should adopt standardized frameworks, enhance multidisciplinary collaboration, ensure editorial independence, and integrate evidence-based medicine to improve quality and clinical utility.

Indexed as

Infertility, MalePractice Guidelines as TopicEvidence-Based MedicineHumansMaleAGREE IIguidelinemale infertilityquality evaluation

Identifiers

PMID41025162
PMCPMC12484906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.